A patient with uncontrolled asthma presents with increased respiratory distress, diminished breath sounds, and requires supplemental oxygen. Despite initial treatment with Albuterol, her condition does not improve, and systemic corticosteroids are being considered. The arterial blood gas analysis shows respiratory alkalosis with a PaO2 of 58 mmHg. What is the most appropriate nursing intervention to prioritize at this time?

B) Increase the frequency of Albuterol nebulizations to manage bronchospasm.

C) Administer an intravenous bolus of normal saline to address potential hypovolemia.

D) Encourage the patient to perform pursed-lip breathing to enhance CO2 elimination.

A patient in the emergency department with an asthma exacerbation shows signs of respiratory distress despite initial treatment with Albuterol. The healthcare team is considering systemic corticosteroids and non-invasive positive pressure ventilation. What is the primary nursing intervention to prioritize at this time to improve the patient's respiratory status?

D) Set up non-invasive positive pressure ventilation to support breathing.

A) Administer a high-flow oxygen mask to increase oxygen saturation quickly.

B) Prepare the patient for immediate intubation to secure the airway.

C) Initiate systemic corticosteroid therapy to reduce airway inflammation.

D) Set up non-invasive positive pressure ventilation to support breathing.

A patient with a history of asthma is hospitalized with an acute exacerbation. After treatment with systemic corticosteroids and initiation of non-invasive positive pressure ventilation (NIPPV), the patient's condition begins to stabilize. As part of discharge planning, which nursing intervention is most crucial to prevent future asthma exacerbations?

B) Educating the patient on the correct use of her maintenance inhaler

A) Prescribing an increased dose of corticosteroids for home use

B) Educating the patient on the correct use of her maintenance inhaler

C) Recommending the patient avoid all physical activity

D) Scheduling a follow-up appointment with a cardiologist

A patient with asthma is admitted with severe respiratory distress despite systemic corticosteroids and supplemental oxygen. After initiating non-invasive positive pressure ventilation (NIPPV), her respiratory rate decreases, and oxygen saturation stabilizes. An arterial blood gas shows a pH of 7.45, PaCO2 of 35 mmHg, and PaO2 of 64 mmHg. What is the most appropriate next step in the management of this patient?

A) Continue current management and monitor closely

B) Increase the level of NIPPV support

C) Initiate invasive mechanical ventilation

D) Administer an intravenous bronchodilator

A patient with poorly controlled asthma is experiencing worsening hypoxemia despite initial stabilization with NIPPV. Her ABG shows a PaO2 of 58 mmHg, and she is now experiencing increased respiratory effort and anxiety. Which of the following nursing interventions is the most appropriate to prioritize at this time?

B) Administer a prescribed dose of intravenous magnesium sulfate.

A) Increase the flow rate of supplemental oxygen via NIPPV.

B) Administer a prescribed dose of intravenous magnesium sulfate.

C) Encourage the patient to perform pursed-lip breathing exercises.

D) Prepare the patient for possible intubation and mechanical ventilation.

A patient with asthma is experiencing worsening hypoxemia despite non-invasive positive pressure ventilation (NIPPV). Which of the following interventions should the nurse prioritize to address the patient's current respiratory distress?

B) Administer a bolus of intravenous magnesium sulfate as ordered.

A) Increase the settings on the NIPPV to improve oxygenation.

B) Administer a bolus of intravenous magnesium sulfate as ordered.

C) Initiate high-flow oxygen therapy to improve oxygen saturation.

D) Request a consult for possible endotracheal intubation.

A patient with severe asthma exacerbation is experiencing persistent tachypnea and oxygen saturation fluctuations despite treatment with nebulized bronchodilators, intravenous magnesium sulfate, and systemic corticosteroids. Her serum potassium level is 3.2 mmol/L. What is the most appropriate immediate nursing intervention to address her current condition?

B) Initiate potassium supplementation

A) Increase the frequency of albuterol nebulizations

B) Initiate potassium supplementation

C) Prepare for possible intubation

D) Administer a rapid-acting insulin for hyperglycemia

A patient with severe asthma exacerbation is admitted to a higher level of care unit. Despite optimized bronchodilator therapy and corticosteroid administration, the patient's respiratory status remains compromised with evidence of hypokalemia. Which nursing intervention is most appropriate to prioritize at this time?

D) Implement continuous cardiac monitoring due to electrolyte imbalance.

A) Initiate high-flow nasal cannula to improve oxygenation.

B) Administer a potassium-sparing diuretic to manage hypokalemia.

C) Increase the frequency of nebulized bronchodilator treatments.

D) Implement continuous cardiac monitoring due to electrolyte imbalance.

A patient with severe asthma exacerbation is experiencing acute respiratory failure, and the clinical team has initiated invasive mechanical ventilation. The patient is showing signs of agitation and confusion. Which nursing intervention is the priority to address the patient’s current clinical status?

B) Assess the patient’s oxygenation status and ensure adequate ventilation settings.

A) Increase the rate of intravenous sedation to ensure the patient remains calm.

B) Assess the patient’s oxygenation status and ensure adequate ventilation settings.

C) Administer a higher dose of bronchodilator to alleviate bronchospasm.

D) Consult with the psychiatry team to address potential steroid-induced psychosis.

A patient with severe asthma exacerbation has been intubated and placed on mechanical ventilation. The most recent arterial blood gas analysis reveals a pH of 7.30, PaCO2 of 55 mmHg, and HCO3- of 24 mEq/L. The patient is also showing signs of agitation and confusion. What is the priority nursing intervention to address the patient's current clinical status?

C) Initiate a continuous infusion of bronchodilators to reduce airway resistance.

A) Increase the tidal volume setting on the ventilator to improve ventilation.

B) Administer a bolus of intravenous sedation to calm the patient.

C) Initiate a continuous infusion of bronchodilators to reduce airway resistance.

D) Conduct a neurological assessment to evaluate the patient's mental status.

Asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Asthma is characterized by chronic inflammation of the airways, leading to hyperresponsiveness. This inflammation is primarily driven by the release of inflammatory mediators such as histamines, leukotrienes, and cytokines, which cause swelling and increased mucus production, resulting in narrowed airways and breathing difficulties.

• Secondary mechanism: Bronchoconstriction, or the tightening of the smooth muscles surrounding the airways, further exacerbates the narrowing of air passages. This is triggered by exposure to allergens, irritants, or other triggers, leading to acute asthma symptoms like wheezing and shortness of breath.

• Key complication: If not effectively managed, chronic inflammation and repeated bronchoconstriction can lead to airway remodeling, where structural changes in the airway walls occur. This can cause irreversible narrowing and reduced lung function over time, complicating long-term asthma management.

Patient Profile

Demographics:

45-year-old female, school teacher

History:

• Key past medical history: Asthma diagnosed 10 years ago, seasonal allergic rhinitis

• Current medications: Fluticasone/Salmeterol inhaler, Montelukast, Albuterol as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing

• Key symptoms: Persistent cough, chest tightness, difficulty breathing, fatigue, mild fever

• Vital signs: Blood pressure 138/86 mmHg, heart rate 102 bpm, respiratory rate 24 breaths per minute, temperature 99.4°F, oxygen saturation 91% on room air

Section 1

As the patient undergoes further assessment in the emergency department, the healthcare team notes that her respiratory status continues to decline despite the initial administration of Albuterol. Her wheezing is now more pronounced, and she exhibits accessory muscle use, indicating increased respiratory effort. Upon auscultation, diminished breath sounds are noted in the lower lobes, suggesting potential mucus plugging or more significant airway obstruction. There is also an increase in her respiratory rate to 28 breaths per minute, and her oxygen saturation has dropped to 88% on room air, necessitating supplemental oxygen.

A chest X-ray is performed to rule out pneumonia or other complications, and while it does not show any acute infiltrates, there is evidence of hyperinflation consistent with uncontrolled asthma. Blood tests reveal an elevated white blood cell count, likely reflecting an inflammatory response, and an elevated eosinophil count, suggesting an allergic component. Arterial blood gas analysis shows respiratory alkalosis with a pH of 7.48, PaCO2 of 32 mmHg, and PaO2 of 58 mmHg, indicative of hypoxemic respiratory distress.

Despite these interventions, the patient’s condition remains tenuous, prompting the consideration of additional treatments. The healthcare team deliberates the potential use of systemic corticosteroids to address the underlying inflammation and reduce airway hyperresponsiveness. There is also discussion regarding the escalation of care, including the potential need for non-invasive positive pressure ventilation to improve oxygenation and reduce the work of breathing. The multidisciplinary team, including a pulmonologist, is consulted to provide a comprehensive approach to managing this acute exacerbation while considering the patient's long-term asthma control strategy.

Section 2

As the healthcare team initiates systemic corticosteroids, the patient is monitored closely for any signs of improvement or further deterioration. Within an hour, her respiratory effort remains significant, and the use of accessory muscles persists. Her respiratory rate has increased to 32 breaths per minute, and although supplemental oxygen has improved her oxygen saturation slightly to 92%, she continues to exhibit signs of respiratory distress. The decision is made to initiate non-invasive positive pressure ventilation (NIPPV) to assist with ventilation and reduce the work of breathing.

The application of NIPPV stabilizes the patient's oxygen saturation at 94%, and her respiratory rate decreases slightly to 28 breaths per minute, indicating a partial response to the intervention. However, the patient's heart rate remains elevated at 110 beats per minute, and she continues to appear anxious and fatigued. Repeat arterial blood gas analysis shows a pH of 7.45, PaCO2 of 35 mmHg, and PaO2 of 64 mmHg, suggesting a slight improvement in ventilation but persistent hypoxemia. The healthcare team discusses the ongoing management strategy, emphasizing the need for continuous monitoring and reevaluation of the treatment plan.

In the interim, a comprehensive review of the patient's medication adherence and asthma action plan is conducted, revealing occasional lapses in the use of her maintenance inhaler. This insight prompts the team to consider additional education and follow-up with the patient to optimize her long-term asthma control. The involvement of a respiratory therapist and an asthma educator is planned to enhance the patient's understanding and management of her condition, aiming to prevent future exacerbations. As the patient begins to stabilize, the focus shifts to refining her discharge plan, ensuring she has the necessary resources and support to manage her asthma effectively outside the hospital setting.

Section 3

Despite the initial stabilization with NIPPV, the patient's condition begins to change over the next few hours. The healthcare team notices that her respiratory rate, which had initially decreased, is now fluctuating between 30 to 34 breaths per minute. Furthermore, her oxygen saturation, though previously stable at 94%, begins to dip to 90% intermittently despite continued NIPPV support. The patient remains visibly anxious and is now reporting difficulty speaking in full sentences, indicating increased respiratory effort. Her accessory muscle use becomes more pronounced, and there is a noticeable wheeze on auscultation of the lungs, suggesting ongoing airway obstruction.

In response to these developments, a repeat arterial blood gas analysis is conducted, revealing a pH of 7.44, PaCO2 of 38 mmHg, and PaO2 of 58 mmHg. These results indicate a worsening hypoxemia and suggest that the current interventions are insufficient in managing her respiratory compromise. Additionally, a chest X-ray is performed to rule out other complications such as pneumothorax or pneumonia, which could exacerbate her respiratory distress. The imaging reveals hyperinflated lungs but no acute infiltrates or evidence of pneumothorax, confirming that the primary issue remains her poorly controlled asthma.

As the team deliberates on the next steps, the patient's anxiety and fatigue are considered as factors that could further impair her respiratory function. The decision is made to escalate her care by transitioning to continuous monitoring in a higher level of care unit, where she can receive closer observation and potentially more aggressive interventions if necessary. The plan includes optimizing her bronchodilator therapy and considering adjunctive treatments such as magnesium sulfate, while also reinforcing her asthma education and adherence strategies. The interdisciplinary team remains vigilant, recognizing the need to balance immediate respiratory support with long-term management to prevent future exacerbations.

Section 4

As the patient is transferred to the higher level of care unit, the healthcare team conducts a thorough initial assessment to guide the next steps in management. Upon arrival, her vital signs are closely monitored, revealing a heart rate of 110 beats per minute, blood pressure of 140/88 mmHg, and a persistently elevated respiratory rate fluctuating between 32 to 36 breaths per minute. Her oxygen saturation remains unstable, intermittently dropping to 88% despite NIPPV, indicating the need for more aggressive interventions. The patient's anxiety is palpable, further contributing to her respiratory distress. Upon auscultation, the wheezing has become more pronounced, especially in the upper lobes, and there is increased use of accessory muscles, highlighting the severity of her airway obstruction.

In addition to optimizing bronchodilator therapy with increased frequency of nebulized albuterol and ipratropium, the team administers intravenous magnesium sulfate, aiming to relax the bronchial smooth muscles and improve airflow. Concurrently, systemic corticosteroids are continued to address the underlying inflammation. Despite these efforts, the patient's condition remains precarious, with transient improvements in oxygen saturation but persistent tachypnea and respiratory effort. Recognizing the potential for respiratory muscle fatigue, the team discusses the possibility of escalating ventilatory support if her condition does not stabilize.

The patient's laboratory results return, providing further insight into her current metabolic status. Her serum potassium is 3.2 mmol/L, indicative of hypokalemia likely secondary to beta-agonist therapy, which could further complicate her respiratory muscle function. The team initiates potassium supplementation while monitoring her electrolyte levels closely. Her blood glucose is elevated at 180 mg/dL, a known side effect of corticosteroid treatment, necessitating regular monitoring and potential insulin administration if hyperglycemia persists. The interdisciplinary team remains vigilant, balancing immediate therapeutic needs with the overarching goal of stabilizing her condition and preventing further deterioration.

Section 5

As the team intensifies their focus on the patient's management, new diagnostic results reveal a concerning development. The arterial blood gas analysis shows a pH of 7.30, PaCO2 of 55 mmHg, and HCO3- of 24 mEq/L, indicating a mixed respiratory and metabolic acidosis. This finding suggests that the patient is experiencing acute respiratory failure, likely due to inadequate ventilation and carbon dioxide retention, despite the current supportive measures. The chest X-ray obtained reveals mild hyperinflation without significant infiltrates, ruling out concurrent pneumonia but highlighting the extent of air trapping consistent with severe asthma exacerbation.

Given these developments, the clinical team prioritizes the adjustment of the patient's ventilatory support. The decision is made to initiate invasive mechanical ventilation to ensure adequate oxygenation and carbon dioxide removal, recognizing the risk of respiratory muscle fatigue worsening without intervention. Additionally, the team considers the potential need for a continuous infusion of bronchodilators in conjunction with sedation to optimize ventilation and reduce the work of breathing. Electrolyte management remains crucial, with ongoing potassium supplementation to maintain levels within the normal range, as hypokalemia could exacerbate muscle weakness under sedation.

Despite the escalation in care, new complications arise as the patient begins to show signs of agitation and confusion, suggestive of possible hypoxia-related encephalopathy or steroid-induced psychosis. Neurological assessments are conducted to evaluate her mental status more thoroughly, while maintaining a delicate balance between sedation for ventilation and the need for neurological clarity. These developments prompt the team to consult with neurology and psychiatry specialists to explore potential interventions and mitigate further cognitive decline. The patient's journey now hinges on the team's ability to stabilize her respiratory status while addressing these emerging complications, underscoring the complexity of her condition and the need for continued multidisciplinary collaboration.